MYLK and cancer: Paul et al. [58] studied 28 matched cases and observed seven genes that were preferentially mutated in metastases—MYLK, PEAK1, SLC2A4RG, EVC2, XIRP2, PALB2, and ESR1—five of which are not significantly mutated in any type of human primary cancer.